Company: BOF
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001493152-25-023178
Chunk: 8

Company: BranchOut Food Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 8
---
 upon conversion of $3,400,000 of outstanding principal under a convertible note with a conversion price 
 of $0.7582 per share, and additional shares of common stock issuable upon conversion of accrued interest under such note;             |
| ● | 1,333,470                                                                                                                             
 shares of our common issuable upon exercise of outstanding stock options having a weighted average exercise price of $2.20 per share; |
| ● | 299,530                                                                                                                               
 shares of our common stock reserved for future issuance under our 2022 Equity Incentive Plan;                                         |
| ● | 2,074,202                                                                                                                             
 shares of our common issuable upon exercise of outstanding warrants having a weighted average exercise price of $2.46 per share;      
 and                                                                                                                                   |
| ● | 41,384                                                                                                                                
 shares of our common stock issuable upon exercise of the Representative’s Warrant.                                                    |

| S-7 |

<div align='center'>DESCRIPTION OF THE SECURITIES WE ARE OFFERING</div>

Common Stock

A description of the common stock we are offering pursuant to this prospectus supplement is set forth under the heading “Description of Common Stock,” starting on page 7 of the accompanying prospectus. As of November 14, 2025, we had 12,345,859 shares of common stock outstanding.

| S-8 |

<div align='center'>UNDERWRITING</div>

Alexander Capital L.P. is acting as the representative of the underwriters of the offering. We have entered into an underwriting agreement dated November __, 2025 with the representative. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriter named below and the underwriter named below has agreed to purchase, at the public offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus supplement, the following number of shares of our common stock:

| Underwriter            |     | Number of Shares |           |
| Alexander Capital L.P. |     |                  | 1,034,600 |
| Total                  |     |                  | 1,034,600 |

The underwriters have committed to purchase all of the shares of common stock offered by us. The obligations of the underwriters may be terminated upon the occurrence of certain events specified in the underwriting agreement. Furthermore, pursuant to the underwriting agreement, the underwriters’ obligations are subject to customary conditions, representations and warranties contained in the under